BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 25450263)

  • 1. Antimicrobial hydrogels: a new weapon in the arsenal against multidrug-resistant infections.
    Ng VW; Chan JM; Sardon H; Ono RJ; García JM; Yang YY; Hedrick JL
    Adv Drug Deliv Rev; 2014 Nov; 78():46-62. PubMed ID: 25450263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial hydrogels: promising materials for medical application.
    Yang K; Han Q; Chen B; Zheng Y; Zhang K; Li Q; Wang J
    Int J Nanomedicine; 2018; 13():2217-2263. PubMed ID: 29695904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Block copolymer mixtures as antimicrobial hydrogels for biofilm eradication.
    Lee AL; Ng VW; Wang W; Hedrick JL; Yang YY
    Biomaterials; 2013 Dec; 34(38):10278-86. PubMed ID: 24090835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial polymers as synthetic mimics of host-defense peptides.
    Kuroda K; Caputo GA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(1):49-66. PubMed ID: 23076870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles incorporated hydrogels for delivery of antimicrobial agents: developments and trends.
    Ahmad N; Bukhari SNA; Hussain MA; Ejaz H; Munir MU; Amjad MW
    RSC Adv; 2024 Apr; 14(19):13535-13564. PubMed ID: 38665493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic stewardship in the intensive care unit.
    Arnold HM; Micek ST; Skrupky LP; Kollef MH
    Semin Respir Crit Care Med; 2011 Apr; 32(2):215-27. PubMed ID: 21506058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents.
    Dawson RM; Liu CQ
    Crit Rev Microbiol; 2008; 34(2):89-107. PubMed ID: 18568863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies employed in the design and optimization of synthetic antimicrobial peptide amphiphiles with enhanced therapeutic potentials.
    Ong ZY; Wiradharma N; Yang YY
    Adv Drug Deliv Rev; 2014 Nov; 78():28-45. PubMed ID: 25453271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial effects of TiO(2) and Ag(2)O nanoparticles against drug-resistant bacteria and leishmania parasites.
    Allahverdiyev AM; Abamor ES; Bagirova M; Rafailovich M
    Future Microbiol; 2011 Aug; 6(8):933-40. PubMed ID: 21861623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and development of a synthetic peptide derived from lactoferrin for clinical use.
    Brouwer CP; Rahman M; Welling MM
    Peptides; 2011 Sep; 32(9):1953-63. PubMed ID: 21827807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in the Development of Antimicrobial Nanoparticles for Combating Resistant Pathogens.
    Lakshminarayanan R; Ye E; Young DJ; Li Z; Loh XJ
    Adv Healthc Mater; 2018 Jul; 7(13):e1701400. PubMed ID: 29717819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes.
    Rudramurthy GR; Swamy MK; Sinniah UR; Ghasemzadeh A
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27355939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case for pathogen-specific therapy.
    Casadevall A
    Expert Opin Pharmacother; 2009 Aug; 10(11):1699-703. PubMed ID: 19558338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance: international control strategies, with a focus on limited-resource settings.
    Diazgranados CA; Cardo DM; McGowan JE
    Int J Antimicrob Agents; 2008 Jul; 32(1):1-9. PubMed ID: 18550343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.
    Ong ZY; Cheng J; Huang Y; Xu K; Ji Z; Fan W; Yang YY
    Biomaterials; 2014 Jan; 35(4):1315-25. PubMed ID: 24211081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future challenges in the development of antimicrobial agents.
    Rennie RP
    Handb Exp Pharmacol; 2012; (211):45-65. PubMed ID: 23090595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.